SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-028415
Filing Date
2021-04-26
Accepted
2021-04-26 19:49:15
Documents
2
Period of Report
2021-04-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2961
2 EX-24 DOCUMENT attachment1.htm EX-24 2153
  Complete submission text file 0001209191-21-028415.txt   6551
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Issuer) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ATRECA INC. 500 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address
Decker Lisa Lynn (Reporting) CIK: 0001783056 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39045 | Film No.: 21855513